These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 14710230

  • 1. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients.
    Itoi T, Yamana K, Bilim V, Takahashi K, Tomita F.
    Br J Cancer; 2004 Jan 12; 90(1):200-5. PubMed ID: 14710230
    [Abstract] [Full Text] [Related]

  • 2. The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.
    Zhu Z, Xing S, Cheng P, Li G, Yang Y, Zeng F, Lu G.
    J Huazhong Univ Sci Technolog Med Sci; 2004 Jan 12; 24(4):354-7. PubMed ID: 15587397
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: no evidence for prognostic significance.
    Hofmockel G, Wittmann A, Dammrich J, Bassukas ID.
    Anticancer Res; 1996 Jan 12; 16(6B):3807-11. PubMed ID: 9042262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth.
    Shin Lee J, Seok Kim H, Bok Kim Y, Cheol Lee M, Soo Park C.
    J Surg Oncol; 2003 Nov 12; 84(3):166-72. PubMed ID: 14598361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
    Xie X, Clausen OP, De Angelis P, Boysen M.
    Cancer; 1999 Sep 15; 86(6):913-20. PubMed ID: 10491515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
    Tomita Y, Bilim V, Kawasaki T, Takahashi K, Okan I, Magnusson KP, Wiman KG.
    Int J Cancer; 1996 May 03; 66(3):322-5. PubMed ID: 8621251
    [Abstract] [Full Text] [Related]

  • 15. Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas.
    Pepe S, Ruggiero A, D'Acquisto M, De Laurentiis M, De Placido S, Sandomenico C, Staibano S, De Rosa G, Lucariello A, D'Armiento M, Bianco AR.
    Cancer; 2000 Sep 01; 89(5):1065-75. PubMed ID: 10964337
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C.
    Urology; 2004 Apr 01; 63(4):651-5. PubMed ID: 15072872
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B, Miki T.
    J Clin Oncol; 2005 Jan 20; 23(3):448-54. PubMed ID: 15572731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.